Semler Scientific, a publicly traded healthcare technology company (Nasdaq: SMLR), has filed with the U.S. Securities and Exchange Commission to offer up to $500 million in securities. This significant move points to the company’s deepening commitment to its Bitcoin investment strategy.
The announcement comes shortly after Semler agreed to pay $29.75 million to settle claims from the U.S. Department of Justice regarding the marketing of its QuantaFlo product. To cover this amount, the company is using a loan from crypto exchange Coinbase, secured against its existing Bitcoin holdings.
As of February 2025, Semler held 3,192 BTC, valued at approximately $267 million based on its most recent SEC filing. Having entered the Bitcoin market in mid-2024, the company purchased its holdings at an average price of $87,854 per coin. Since then, it has embraced a new key performance metric dubbed “BTC Yield,” boasting a 152.2% year-to-date return as of early 2025.
Future Plans and Industry Context
Although the new $500 million securities offering outlines several potential uses, strong indications suggest that increased Bitcoin accumulation is a central focus. This strategic direction puts Semler alongside other corporate Bitcoin adopters such as:
- Strategy (formerly MicroStrategy), which recently added 3,459 BTC to its portfolio, maintaining its status as the leading corporate holder.
- Metaplanet, which continues its investment push and now ranks as the 10th largest corporate Bitcoin holder globally.
Semler’s assertive approach highlights a growing trend of public companies integrating Bitcoin into their treasury management practices. With market volatility persisting, Bitcoin is increasingly seen as a strategic financial asset.
For additional information, see the original article on Blockhead.